# A Study to Test Whether Study Drug BAY1128688 Brings Pain Relief to Women With Endometriosis and if so to Get a First Idea Which Dose(s) Work Best

> **NCT03373422** · PHASE2 · TERMINATED · sponsor: **Bayer** · enrollment: 121 (actual)

## Conditions studied

- Endometriosis

## Interventions

- **DRUG:** BAY1128688
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03373422
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-11-30
- **Primary completion:** 2018-07-23
- **Final completion:** 2018-10-22
- **Target enrollment:** 121 (ACTUAL)
- **Why stopped:** Study BAY1128688/17472 (AKRENDO 1) was terminated early on 20 July 2018 due to hepatotoxicity
- **Last updated:** 2019-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03373422

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03373422, "A Study to Test Whether Study Drug BAY1128688 Brings Pain Relief to Women With Endometriosis and if so to Get a First Idea Which Dose(s) Work Best". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03373422. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*